Rufinamide structure
|
Common Name | Rufinamide | ||
---|---|---|---|---|
CAS Number | 106308-44-5 | Molecular Weight | 238.193 | |
Density | 1.5±0.1 g/cm3 | Boiling Point | 473.8±55.0 °C at 760 mmHg | |
Molecular Formula | C10H8F2N4O | Melting Point | 232-234?C | |
MSDS | Chinese USA | Flash Point | 240.4±31.5 °C |
Use of RufinamideRufinamide(E 2080; CGP 33101; RUF 331) is a new antiepileptic agent that differs structurally from other antiepileptic drugs and is approved as adjunctive therapy for Lennox-Gastaut syndrome (LGS).IC50 Value:Target: in vitro:in vivo: Rufinamide and amitriptyline alleviated injury-induced mechanical allodynia for 4 h (maximal effect: 0.10 ± 0.03 g (mean ± SD) to 1.99 ± 0.26 g for rufinamide and 0.25 ± 0.22 g to 1.92 ± 0.85 g for amitriptyline) in mice [1]. Oral rufinamide suppressed pentylenetetrazol-induced seizures in mice (ED(50) 45.8 mg/kg) but not rats, and was active against MES-induced tonic seizures in mice (ED(50) 23.9 mg/kg) and rats (ED(50) 6.1 mg/kg) [2]. Intraperitoneal rufinamide suppressed pentylenetetrazol-, bicuculline-, and picrotoxin-induced clonus in mice (ED(50) 54.0, 50.5, and 76.3 mg/kg, respectively).Clinical trial: Exploratory Study to Evaluate the Effect of SYN-111 (Rufinamide) in Patients With Generalized Anxiety Disorder (GAD). Phase 2 |
Name | Rufinamide |
---|---|
Synonym | More Synonyms |
Description | Rufinamide(E 2080; CGP 33101; RUF 331) is a new antiepileptic agent that differs structurally from other antiepileptic drugs and is approved as adjunctive therapy for Lennox-Gastaut syndrome (LGS).IC50 Value:Target: in vitro:in vivo: Rufinamide and amitriptyline alleviated injury-induced mechanical allodynia for 4 h (maximal effect: 0.10 ± 0.03 g (mean ± SD) to 1.99 ± 0.26 g for rufinamide and 0.25 ± 0.22 g to 1.92 ± 0.85 g for amitriptyline) in mice [1]. Oral rufinamide suppressed pentylenetetrazol-induced seizures in mice (ED(50) 45.8 mg/kg) but not rats, and was active against MES-induced tonic seizures in mice (ED(50) 23.9 mg/kg) and rats (ED(50) 6.1 mg/kg) [2]. Intraperitoneal rufinamide suppressed pentylenetetrazol-, bicuculline-, and picrotoxin-induced clonus in mice (ED(50) 54.0, 50.5, and 76.3 mg/kg, respectively).Clinical trial: Exploratory Study to Evaluate the Effect of SYN-111 (Rufinamide) in Patients With Generalized Anxiety Disorder (GAD). Phase 2 |
---|---|
Related Catalog | |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 473.8±55.0 °C at 760 mmHg |
Melting Point | 232-234?C |
Molecular Formula | C10H8F2N4O |
Molecular Weight | 238.193 |
Flash Point | 240.4±31.5 °C |
Exact Mass | 238.066620 |
PSA | 73.80000 |
LogP | 0.05 |
Vapour Pressure | 0.0±1.2 mmHg at 25°C |
Index of Refraction | 1.635 |
Storage condition | −20°C |
Water Solubility | DMSO: soluble9mg/mL |
Hazard Codes | F,T |
---|---|
Risk Phrases | 11-23/24/25-39/23/24/25-48-41-38-28 |
Safety Phrases | 7-16-36/37-45-36/37/39-28-26-24/25 |
RIDADR | UN 1648 3 / PGII |
Dose-dependent pharmacokinetics and brain penetration of rufinamide following intravenous and oral administration to rats.
Eur. J. Pharm. Sci. 68 , 106-13, (2015) Rufinamide is a third-generation antiepileptic drug, approved recently as an orphan drug for the treatment of Lennox-Gastaut syndrome. Although extensive research was conducted, its pharmacokinetics i... |
|
Toxicological screening of human plasma by on-line SPE-HPLC-DAD: identification and quantification of basic drugs and metabolites.
Biomed. Chromatogr. 29 , 935-52, (2015) An automated multi-analyte screening method for the identification and quantification of 92 drugs and metabolites based on on-line solid-phase extraction-high-performance liquid chromatography-diode a... |
|
Rufinamide for the treatment of Lennox-Gastaut syndrome.
Expert Opin. Pharmacother. 12(5) , 801-6, (2011) Lennox-Gastaut syndrome (LGS) is a severe treatment-resistant childhood-onset epilepsy. This review examines the role of the new drug rufinamide for the treatment of LGS.MEDLINE and Google Scholar sea... |
1-[(2,6-difluorophenyl)methyl]-1H-1,2,3-Triazole-4-carboxamide |
1-(2,6-Difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide |
Rufinamide |
1H-1,2,3-Triazole-4-carboxamide, 1-[(2,6-difluorophenyl)methyl]- |
1-((2,6-Difluorophenyl)methyl)-1H-1,2,3-triazole-4-carboxamide |
Banzel |
Inovelon |